Biotech IPOs are reopening—but selectively.
Kailera Therapeutics and Alamar Biosciences show what the market wants now: late-stage, legible stories investors can actually underwrite.
Our latest:
https://biotech.industryexaminer.com/biotech-ipo-window-reopening-selective-2026/
CAPITAL MARKETS FIGURE ROY ZIMMERHANSIL APPOINTED TO LEAD NEW DIVISION AT WTS HANSKUE
Roy Zimmerhansl, with 20+ years experience, now leads WTS Hansuke's new Capital Markets division in London, focusing on digital assets and traditional finance.
#CapitalMarkets, #DigitalAssets, #WTSHansuke, #RoyZimmerhansl, #FinanceNews
https://newsletter.tf/roy-zimmerhansl-leads-wts-hansuke-capital-markets-division/
WTS Hansuke has appointed Roy Zimmerhansl to lead their new Capital Markets division, a move that expands their focus to include digital assets alongside traditional finance.
#CapitalMarkets, #DigitalAssets, #WTSHansuke, #RoyZimmerhansl, #FinanceNews
https://newsletter.tf/roy-zimmerhansl-leads-wts-hansuke-capital-markets-division/
EastWest Bank helped raise billions for Maynilad and SM Prime last year -- and just won regional awards for both deals. 🏆💼 Here's what they pulled off 👇
#EastWestBank #CapitalMarkets #BankingPH
https://astig.ph/eastwest-bank-alpha-southeast-asia-awards-2025-maynilad-sm-prime/

MANILA, Philippines (Mar 2026) — Two of the biggest financing deals in the Philippines last year had EastWest Bank behind them, and the bank just picked up regional recognition for both. EastWest s…